Hemodialysis

Essential Role of Ultrapure Dialysis Fluid Highlighted on World Patient Safety Day

Thursday, September 17, 2020 - 1:05am
Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20200916005511/en/
    Fresenius Medical Care today announced the launch of the organizations first World Patient Safety Day initiative to raise awareness of the importance of ultrapure dialysis fluid for developing economies across Asia Pacific.
  • We have chosen World Patient Safety Day to highlight the importance of this issue.
  • These will begin with an online symposium presented on World Patient Safety Day, Does Ultrapure Dialysis Fluid Matter in Hemodialysis?
  • For more information about Ultrapure Dialysis Fluid, please visit: https://bit.ly/3moMk0Q
    The online symposium Does Ultrapure Dialysis Fluid Matter in Hemodialysis?

Quanta to Host Expert Perspectives Webinar on Home Dialysis

Tuesday, September 15, 2020 - 12:00pm

Alcester, Warwickshire, UK, 15 September 2020: Quanta Dialysis Technologies Ltd (Quanta or the Company), a British medical technology innovation company, today announces that it will be hosting an Expert Perspectives Webinar on home dialysis on Monday 21 September at 4pm BST / 11am EDT.

Key Points: 
  • Alcester, Warwickshire, UK, 15 September 2020: Quanta Dialysis Technologies Ltd (Quanta or the Company), a British medical technology innovation company, today announces that it will be hosting an Expert Perspectives Webinar on home dialysis on Monday 21 September at 4pm BST / 11am EDT.
  • The presentation will be followed by a live moderated Q&A with the panel and audience by Tina Tan, Executive Editor at FirstWord MedTech.
  • The management team at Quanta Dialysis Technologies will also be available to discuss SC+, its small, simple and versatile haemodialysis system.
  • How quickly will dialysis be adopted routinely in North America?

Quanta to Host Expert Perspectives Webinar on Home Dialysis

Tuesday, September 15, 2020 - 8:00am

Alcester, Warwickshire, UK, 15 September 2020: Quanta Dialysis Technologies Ltd (Quanta or the Company), a British medical technology innovation company, today announces that it will be hosting an Expert Perspectives Webinar on home dialysis on Monday 21 September at 4pm BST / 11am EDT.

Key Points: 
  • Alcester, Warwickshire, UK, 15 September 2020: Quanta Dialysis Technologies Ltd (Quanta or the Company), a British medical technology innovation company, today announces that it will be hosting an Expert Perspectives Webinar on home dialysis on Monday 21 September at 4pm BST / 11am EDT.
  • The presentation will be followed by a live moderated Q&A with the panel and audience by Tina Tan, Executive Editor at FirstWord MedTech.
  • The management team at Quanta Dialysis Technologies will also be available to discuss SC+, its small, simple and versatile haemodialysis system.
  • How quickly will dialysis be adopted routinely in North America?

Ellipsys System Offers Greater Patient Eligibility and Reduced Time to Dialysis

Thursday, September 10, 2020 - 1:10pm

The Ellipsys System had a technical success rate of 100 percent, and only 27.7 percent of patients required secondary interventions following fistula creation.

Key Points: 
  • The Ellipsys System had a technical success rate of 100 percent, and only 27.7 percent of patients required secondary interventions following fistula creation.
  • Overall, 79.5 percent of Ellipsys patients and 58 percent of WavelinQ patients were able to successfully begin dialysis with their fistula.
  • "For every patient, my goal is to create the best possible dialysis access with the fewest possible interventions," said Dr. Shahverdyan.
  • The company's Ellipsys Vascular Access System is an innovative, ultrasound-guided, single-catheter endoAVF system used to percutaneously create an arteriovenous fistula for hemodialysis access.

Rockwell Medical to Host Conference Call and Webcast with Management and Key Opinion Leaders to Discuss Potential Novel Indications for Its FPC Platform

Wednesday, September 9, 2020 - 1:00pm

The call and webcast will include representatives from Rockwell Medical as well as key opinion leaders (KOLs) Connie Sullivan, B.S.

Key Points: 
  • The call and webcast will include representatives from Rockwell Medical as well as key opinion leaders (KOLs) Connie Sullivan, B.S.
  • (Oxon), Emeritus Professor of Medicine at the University of Minnesota Medical School and Former Director of the Heart Failure Program at VA Medical Center in Minneapolis.
  • "My charge as CEO is to actualize the potential of our FPC technology, for patients and for shareholders, said Russell Ellison, M.D., M.Sc., President and Chief Executive Officer of Rockwell Medical.
  • I believe there is potential for important value creation through the development of the FPC platform to treat medical conditions with unmet clinical needs outside of the hemodialysis setting.

Global Hemodialysis Catheters Market (2020 to 2024) - Featuring Cook Group, Medtronic & Nipro Among Others - ResearchAndMarkets.com

Wednesday, September 9, 2020 - 11:43am

The global hemodialysis catheters market is poised to grow by $190 million during 2020-2024, progressing at a CAGR of 5% during the forecast period.

Key Points: 
  • The global hemodialysis catheters market is poised to grow by $190 million during 2020-2024, progressing at a CAGR of 5% during the forecast period.
  • This report on the hemodialysis catheters market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
  • The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment.
  • This study identifies the advances in technology as one of the prime reasons driving the hemodialysis catheters market growth during the next few years.

Global Hemodialysis Catheters Market 2020-2024: COVID-19 Business Continuity Plan | Evolving Opportunities with AngioDynamics Inc. and B. Braun Melsungen AG | Technavio

Tuesday, September 8, 2020 - 11:45pm
Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20200908005667/en/
    Technavio has announced its latest market research report titled Global Hemodialysis Catheters Market 2020-2024 (Graphic: Business Wire)
    Read the 120-page report with TOC on "Hemodialysis Catheters Market Analysis Report by Product (Long-term hemodialysis catheters and Short-term hemodialysis catheters) and Geography (North America, Europe, APAC, and ROW), and the Segment Forecasts, 2020-2024".
  • In addition, the advances in technology are anticipated to boost the growth of the Hemodialysis Catheters Market.
  • The growing prevalence of CKD is expected to increase the demand for dialysis catheters, especially hemodialysis catheters globally.
  • B. Braun Melsungen AG has business operations under various segments such as B. Braun Hospital Care, B. Braun Aesculap, B. Braun Out Patient Market, and B. Braun Avitum.

Analysis on Impact of COVID-19 - Global Dialyzer Market 2020-2024 | Evolving Opportunities with Asahi Kasei Corp. and B. Braun Melsungen AG | Technavio

Tuesday, September 8, 2020 - 7:00pm

The global dialyzer market size is expected to grow by USD 3.19 billion as per Technavio.

Key Points: 
  • The global dialyzer market size is expected to grow by USD 3.19 billion as per Technavio.
  • In addition, the growing preference toward home dialysis is anticipated to boost the growth of the Dialyzer Market.
  • The growing incidence of CKDs such as ESRD and renal diseases is expected to drive the dialyzer market growth.
  • B. Braun Melsungen AG operates its business through various segments such as B. Braun Hospital Care, B. Braun Aesculap, B. Braun Out Patient Market, and B. Braun Avitum.

Rockwell Medical, Inc. to Present at Upcoming September Investor Conferences

Tuesday, September 8, 2020 - 1:00pm

Rockwell Medical is a biopharmaceutical company dedicated to transforming anemia management in a wide variety of therapeutic areas and across the globe, improving the lives of very sick patients.

Key Points: 
  • Rockwell Medical is a biopharmaceutical company dedicated to transforming anemia management in a wide variety of therapeutic areas and across the globe, improving the lives of very sick patients.
  • Triferic Dialysate and Triferic AVNU are the only FDA-approved therapies in theU.S.indicated to replace iron and maintain hemoglobin in hemodialysis patients during each dialysis treatment.
  • Triferic Dialysate and Triferic AVNU have a unique and differentiated mechanism of action, which has the potential to benefit patients and health care economics.
  • Trifericis a registered trademark ofRockwell Medical, Inc. Triferic AVNU is pending with theU.S.Patent and Trademark Office.

COVID-19 Pandemic Impact on Global Hemodialysis Equipment Market 2020-2024 | Technavio

Wednesday, August 26, 2020 - 2:00pm

With the surging growth of COVID-19 pandemic, the Health Care market is anticipated to have a Direct impact during the forecast period.

Key Points: 
  • With the surging growth of COVID-19 pandemic, the Health Care market is anticipated to have a Direct impact during the forecast period.
  • View market snapshot before purchasing
    Technological advances and new product launches has been an instrumental factor in influencing the growth of hemodialysis equipment market.
  • Technavio offers custom research analysis on the crucial pointers to highlight the impact of COVID-19 on the market across the supply chain.
  • Key Considerations for Market Forecast:
    Get more insights about the global trends impacting the future of hemodialysis equipment market, Request Free Sample @ https://www.technavio.com/talk-to-us?report=IRTNTR40103
    The market is concentrated, and the degree of concentration will accelerate during the forecast period.